FdaApplication
NDA 020259
Identifiers
- fda_app_no: NDA020259
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1992-11-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEPRON | ATOVAQUONE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product